Israel
Clal Biotechnology Industries (TASE: CBI) is a leading Israeli life sciences investment company. It identifies and supports promising innovative ventures with proprietary solutions to unmet medical needs. CBI holds and manages an international portfolio of some fifteen biotechnology and medical device companies.
17
Total Investments
14
Portfolio Companies
-
Exits
2
Industries
General Information
Industries
Biotechnology, Pharmaceutical
Company Overview
About Clal Biotechnology Industries
Recent Investments (17)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series E | •••••• | Aug 2023 | |
| Series D | •••••• | Aug 2020 | |
| Series B | •••••• | Apr 2020 | |
| Series B | •••••• | Oct 2019 | |
| Post-IPO Equity | •••••• | Apr 2018 | |
•••• ••••
|
Venture Round | •••••• | Oct 2017 |
|
•••• ••••
|
Series F | •••••• | Jun 2017 |
|
•••• ••••
|
Series C - Pi | •••••• | Jan 2016 |
|
•••• ••••
|
Series A | •••••• | Oct 2015 |
|
•••• ••••
|
Venture Round | •••••• | Jun 2013 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
